欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0640/001
药品名称Ondansetron Kabi 2mg/ml Injektionslösung
活性成分
    • ondansetron hydrochloride 2.0 mg/ml
剂型Solution for injection
上市许可持有人Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1 61352 Bad Homburg Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Malta (MT)
      ONDANSETRON KABI 2 MG/ML solution for injection
    • Iceland (IS)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
      Ondansetron Kabi 2 mg/ml
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
      Ondansetron Fresenius Kabi
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Ondansetron Kabi 2 mg/ml roztwor do wstrzykiwan
    • Hungary (HU)
      Ondansetron Kabi 2 mg/ml oldatos injekció
    • Czechia (CZ)
    • Slovakia (SK)
      Ondansetron Kabi 2 mg/ml
许可日期2006/05/22
最近更新日期2023/12/13
药物ATC编码
    • A04AA01 ondansetron
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase